Equities research analysts at StockNews.com began coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Get Free Report) in a report issued on Sunday. The brokerage set a “sell” rating on the biotechnology company’s stock. Genocea Biosciences Stock Performance The company has a market cap of $6,000.00, a price-to-earnings ratio of 0.00 and a beta of […]